Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bone marrow-derived hematopoietic progenitor cells and endothelial progenitor cells as prognostic indicators for cancer

Bone marrow-derived hematopoietic progenitor cells and endothelial progenitor cells as prognostic indicators for cancer

US Patent 9927444 · Granted Mar 27, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stable three-dimensional blood vessels and methods for forming the same2024
Methods and compositions for promoting survival and proliferation of endothelial2024
Methods for organ regeneration2021
Methods and compositions for promoting survival and proliferation of endothelial2020
Methods and compositions for promoting survival and proliferation of endothelial2018
Generation of functional and durable endothelial cells from human amniotic fluid2017
Inhibiting migration of cancer cells2016
Inhibition of angiogenesis2015
Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells2014
Methods for increasing vascular density and maintaining viability of microvascul2014
Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof2013
Use of vascular endothelial growth factor receptor 1+ cells in treating and moni2013